Cargando…
Expression of Concern: Antitumor Activity of Sorafenib in Human Cancer Cell Lines with Acquired Resistance to EGFR and VEGFR Tyrosine Kinase Inhibitors
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6459487/ https://www.ncbi.nlm.nih.gov/pubmed/30973909 http://dx.doi.org/10.1371/journal.pone.0215109 |
| _version_ | 1783410186624434176 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6459487 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | Public Library of Science |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-64594872019-05-03 Expression of Concern: Antitumor Activity of Sorafenib in Human Cancer Cell Lines with Acquired Resistance to EGFR and VEGFR Tyrosine Kinase Inhibitors PLoS One Expression of Concern Public Library of Science 2019-04-11 /pmc/articles/PMC6459487/ /pubmed/30973909 http://dx.doi.org/10.1371/journal.pone.0215109 Text en © 2019 The PLOS ONE Editors http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
| spellingShingle | Expression of Concern Expression of Concern: Antitumor Activity of Sorafenib in Human Cancer Cell Lines with Acquired Resistance to EGFR and VEGFR Tyrosine Kinase Inhibitors |
| title | Expression of Concern: Antitumor Activity of Sorafenib in Human Cancer Cell Lines with Acquired Resistance to EGFR and VEGFR Tyrosine Kinase Inhibitors |
| title_full | Expression of Concern: Antitumor Activity of Sorafenib in Human Cancer Cell Lines with Acquired Resistance to EGFR and VEGFR Tyrosine Kinase Inhibitors |
| title_fullStr | Expression of Concern: Antitumor Activity of Sorafenib in Human Cancer Cell Lines with Acquired Resistance to EGFR and VEGFR Tyrosine Kinase Inhibitors |
| title_full_unstemmed | Expression of Concern: Antitumor Activity of Sorafenib in Human Cancer Cell Lines with Acquired Resistance to EGFR and VEGFR Tyrosine Kinase Inhibitors |
| title_short | Expression of Concern: Antitumor Activity of Sorafenib in Human Cancer Cell Lines with Acquired Resistance to EGFR and VEGFR Tyrosine Kinase Inhibitors |
| title_sort | expression of concern: antitumor activity of sorafenib in human cancer cell lines with acquired resistance to egfr and vegfr tyrosine kinase inhibitors |
| topic | Expression of Concern |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6459487/ https://www.ncbi.nlm.nih.gov/pubmed/30973909 http://dx.doi.org/10.1371/journal.pone.0215109 |
| work_keys_str_mv | AT expressionofconcernantitumoractivityofsorafenibinhumancancercelllineswithacquiredresistancetoegfrandvegfrtyrosinekinaseinhibitors |